Literature DB >> 15919792

The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform.

Gema Medina-Gomez1, Sam Virtue, Christopher Lelliott, Romina Boiani, Mark Campbell, Constantinos Christodoulides, Christophe Perrin, Mercedes Jimenez-Linan, Margaret Blount, John Dixon, Dirk Zahn, Rosemary R Thresher, Sam Aparicio, Mark Carlton, William H Colledge, Mikko I Kettunen, Tuulikki Seppänen-Laakso, Jaswinder K Sethi, Stephen O'Rahilly, Kevin Brindle, Saverio Cinti, Matej Oresic, Remy Burcelin, Antonio Vidal-Puig.   

Abstract

The nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARgamma) is critically required for adipogenesis. PPARgamma exists as two isoforms, gamma1 and gamma2. PPARgamma2 is the more potent adipogenic isoform in vitro and is normally restricted to adipose tissues, where it is regulated more by nutritional state than PPARgamma1. To elucidate the relevance of the PPARgamma2 in vivo, we generated a mouse model in which the PPARgamma2 isoform was specifically disrupted. Despite similar weight, body composition, food intake, energy expenditure, and adipose tissue morphology, male mice lacking the gamma2 isoform were more insulin resistant than wild-type animals when fed a regular diet. These results indicate that insulin resistance associated with ablation of PPARgamma2 is not the result of lipodystrophy and suggests a specific role for PPARgamma2 in maintaining insulin sensitivity independently of its effects on adipogenesis. Furthermore, PPARgamma2 knockout mice fed a high-fat diet did not become more insulin resistant than those on a normal diet, despite a marked increase in their mean adipocyte cell size. These findings suggest that PPARgamma2 is required for the maintenance of normal insulin sensitivity in mice but also raises the intriguing notion that PPARgamma2 may be necessary for the adverse effects of a high-fat diet on carbohydrate metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919792      PMCID: PMC4304004          DOI: 10.2337/diabetes.54.6.1706

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  27 in total

1.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.

Authors:  E D Rosen; P Sarraf; A E Troy; G Bradwin; K Moore; D S Milstone; B M Spiegelman; R M Mortensen
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

3.  Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists.

Authors:  S S Davies; A V Pontsler; G K Marathe; K A Harrison; R C Murphy; J C Hinshaw; G D Prestwich; A S Hilaire; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Biol Chem       Date:  2001-02-26       Impact factor: 5.157

4.  A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms.

Authors:  R K Semple; A Meirhaeghe; A J Vidal-Puig; J W R Schwabe; D Wiggins; G F Gibbons; M Gurnell; V K K Chatterjee; S O'Rahilly
Journal:  Endocrinology       Date:  2005-01-20       Impact factor: 4.736

5.  PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis.

Authors:  Delin Ren; Trevor N Collingwood; Edward J Rebar; Alan P Wolffe; Heidi S Camp
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

6.  Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding.

Authors:  P Escher; O Braissant; S Basu-Modak; L Michalik; W Wahli; B Desvergne
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

Review 7.  Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?

Authors:  Olivier Nosjean; Jean A Boutin
Journal:  Cell Signal       Date:  2002-07       Impact factor: 4.315

Review 8.  Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm.

Authors:  Terrie-Anne Cock; Sander M Houten; Johan Auwerx
Journal:  EMBO Rep       Date:  2004-02       Impact factor: 8.807

9.  Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin.

Authors:  A Werman; A Hollenberg; G Solanes; C Bjorbaek; A J Vidal-Puig; J S Flier
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

10.  Muscle-specific Pparg deletion causes insulin resistance.

Authors:  Andrea L Hevener; Weimin He; Yaacov Barak; Jamie Le; Gautam Bandyopadhyay; Peter Olson; Jason Wilkes; Ronald M Evans; Jerrold Olefsky
Journal:  Nat Med       Date:  2003-11-16       Impact factor: 53.440

View more
  59 in total

1.  The ubiquitin ligase Siah2 regulates PPARγ activity in adipocytes.

Authors:  Gail Kilroy; Heather Kirk-Ballard; Lauren E Carter; Z Elizabeth Floyd
Journal:  Endocrinology       Date:  2012-01-31       Impact factor: 4.736

2.  Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male rats.

Authors:  Jennifer L Cantley; Daniel F Vatner; Thomas Galbo; Anila Madiraju; Max Petersen; Rachel J Perry; Naoki Kumashiro; Fitsum Guebre-Egziabher; Arijeet K Gattu; Mitchel R Stacy; Donald P Dione; Albert J Sinusas; Louis Ragolia; Christopher E Hall; Vara Prasad Manchem; Sanjay Bhanot; Jonathan S Bogan; Varman T Samuel
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

3.  Adipose tissue expandability and the metabolic syndrome.

Authors:  Marc Slawik; Antonio J Vidal-Puig
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

4.  Effects of breeds and dietary protein levels on the growth performance, energy expenditure and expression of avUCP mRNA in chickens.

Authors:  Qihua Li; Zhiqiang Xu; L Liu; Hongxin Yu; Hua Rong; Linli Tao; Xi Zhang; Xiaobo Chen; Dahai Gu; Yueyuan Fan; Xiaoqin Li; Changrong Ge; Yunbo Tian; Junjing Jia
Journal:  Mol Biol Rep       Date:  2013-02-22       Impact factor: 2.316

Review 5.  Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.

Authors:  Robert E Heinl; Devinder S Dhindsa; Elliot N Mahlof; William M Schultz; Johnathan C Ricketts; Tina Varghese; Amirhossein Esmaeeli; Marc P Allard-Ratick; Anthony J Millard; Heval M Kelli; Pratik B Sandesara; Danny J Eapen; Laurence Sperling
Journal:  Can J Cardiol       Date:  2016-07-22       Impact factor: 5.223

6.  Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.

Authors:  Timothy A Simeone; Stephanie A Matthews; Kaeli K Samson; Kristina A Simeone
Journal:  Exp Neurol       Date:  2016-08-12       Impact factor: 5.330

Review 7.  PPARgamma in human and mouse physiology.

Authors:  Sami Heikkinen; Johan Auwerx; Carmen A Argmann
Journal:  Biochim Biophys Acta       Date:  2007-03-27

8.  PPAR-gamma AF-2 domain functions as a component of a ubiquitin-dependent degradation signal.

Authors:  Gail E Kilroy; Xiaoying Zhang; Z Elizabeth Floyd
Journal:  Obesity (Silver Spring)       Date:  2009-01-15       Impact factor: 5.002

9.  Gene dosage effects of the imprinted delta-like homologue 1 (dlk1/pref1) in development: implications for the evolution of imprinting.

Authors:  Simao Teixeira da Rocha; Marika Charalambous; Shau-Ping Lin; Isabel Gutteridge; Yoko Ito; Dionne Gray; Wendy Dean; Anne C Ferguson-Smith
Journal:  PLoS Genet       Date:  2009-02-27       Impact factor: 5.917

10.  Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network.

Authors:  Claire Lagathu; Constantinos Christodoulides; Sam Virtue; William P Cawthorn; Chiara Franzin; Wendy A Kimber; Edoardo Dalla Nora; Mark Campbell; Gema Medina-Gomez; Benjamin N R Cheyette; Antonio J Vidal-Puig; Jaswinder K Sethi
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.